Related Experiment Video
Updated: May 2, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Protection against experimental aspergillosis by heat-killed yeast is not antibody dependent
Karl V Clemons1, Marife Martinez, Vicky Chen
1California Institute for Medical Research, San Jose, CA.
Abstract:
Previously we showed heat-killed yeast (HKY) of Saccharomyces cerevisiae administered as a vaccine are protective against systemic murine aspergillosis (and other mycoses) and that HKY induces antibody and cellular responses. To determine the role of antibodies in this protection, male antibody knockout mice (KO; strain B6.129S2-Igh-6 (tm1Cgn)/J) and C57BL/6 wild-type (WT) mice were vaccinated subcutaneously with 6 × 10(7) HKY or phosphate buffered saline (PBS) given three or four times. Mice were infected intravenously with 6 × 10(6) viable conidia of Aspergillus fumigatus 10AF and mortality tallied through 12 days post infection. HKY vaccination given four times proved protective in the prolongation of survival of WT and KO mice vs. the respective PBS-treated controls. In one study, survival was prolonged in vaccinated WT or KO mice (P < 0.0001). A second study confirmed these results (P < 0.0001). Additionally, a three-dose regimen of HKY was also effective, prolonging survival of WT or KO mice vs. controls (P = 0.0002); no difference was found when the effectiveness of three- or four-dose regimens was compared. No significant differences in survival were found between HKY-vaccinated WT and KO mice, nor were PBS-treated KO mice more susceptible to infection than PBS-treated WT mice. Similar results were noted in another study in which a higher infectious inoculum and a three-dose regimen were used. Overall, antibodies do not appear to play a significant role in HKY-induced prolongation of survival in systemic aspergillosis, nor do antibodies appear to play a role in the innate resistance of the mice to aspergillosis.
Insights
Heat-killed yeast (HKY) vaccination protects against fungal infections in mice. This study found that antibodies are not essential for this protection, suggesting other immune mechanisms are at play in combating aspergillosis.
Area of Science:
- Immunology
- Mycology
- Vaccinology
Background:
- Heat-killed yeast (HKY) of Saccharomyces cerevisiae demonstrates protective effects against systemic murine aspergillosis.
- HKY vaccination is known to elicit both antibody and cellular immune responses.
Purpose of the Study:
- To investigate the specific role of antibodies in the protective immunity conferred by HKY vaccination against systemic murine aspergillosis.
- To compare the efficacy of HKY vaccination in antibody knockout (KO) mice versus wild-type (WT) mice.
Main Methods:
- Male antibody knockout (B6.129S2-Igh-6 (tm1Cgn)/J) and C57BL/6 wild-type mice were vaccinated with HKY or phosphate-buffered saline (PBS).
- Vaccination regimens included three or four doses administered subcutaneously.
- Mice were infected intravenously with Aspergillus fumigatus conidia, and survival was monitored for 12 days.
Main Results:
- HKY vaccination, administered four times, significantly prolonged survival in both WT and KO mice compared to PBS controls (P < 0.0001).
- A three-dose HKY regimen was also effective in prolonging survival (P = 0.0002), with no significant difference between three- and four-dose schedules.
- No significant survival differences were observed between vaccinated WT and KO mice, indicating antibodies are not crucial for HKY-induced protection.
- PBS-treated KO mice showed similar susceptibility to infection as PBS-treated WT mice, suggesting no role for antibodies in innate resistance.
Conclusions:
- Antibodies do not appear to play a significant role in the protective effect of heat-killed yeast (HKY) vaccination against systemic aspergillosis in mice.
- The findings suggest that cellular immunity or other antibody-independent mechanisms are primarily responsible for HKY-mediated protection.
- HKY vaccination offers a promising strategy for aspergillosis prevention, independent of the host's antibody production capacity.
More Related Videos
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
11:06Comparison of Tobacco Host Cell Protein Removal Methods by Blanching Intact Plants or by Heat Treatment of Extracts
Published on: August 8, 2016
Related Concept Videos
Antifungal Agents
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Fungal Phylum Ascomycota
Physical Methods for Controlling Microbial Growth: Temperature